Table 2.

Oncological outcome

Adverse Pathology
#	pT3 and /or postop Gleason score ≥ 7	115/333 (34.5)
	pT3	27/333 (8.0)
	Gleason ≥ 7	105/333 (31.5)
	Gleason score 3+4 = 7	89/105 (84.8)
	Gleason score 4+3 = 7	16/105 (15.2)
	Gleason score ≥8	0/105 (0.0)
Surgical margin status
	Negative	275/329 (83.6)
	Positive	54/329 (16.4)
Surgical margin status pT2
Negative		260/302 (86.1)
Positive		42/302 (13.9)
Surgical margin status pT3
Negative		15/27 (55.6)
Positive		12/27 (44.4)
PSA > 0.1 (ng/ml) 6–12 weeks postoperative
	Yes	7/329 (2.1)
	No	322/329 (97.9)
BCR (PSA ≥ 0.25 ng/ml or salvage treatment) at 12 months
	Yes	8/334 (2.4)
	No	326/334 (97.6)

^#The primary oncological endpoint in the study.